France · Delayed Price · Currency is EUR LNA Santé Statistics
Total Valuation
LNA Santé has a market cap or net worth of EUR 337.45 million. The enterprise value is 1.16 billion.
| Market Cap | 337.45M |
| Enterprise Value | 1.16B |
Important Dates
The last earnings date was Thursday, May 7, 2026.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | Sep 28, 2026 |
Share Statistics
LNA Santé has 10.26 million shares outstanding. The number of shares has increased by 0.33% in one year.
| Current Share Class | 10.26M |
| Shares Outstanding | 10.26M |
| Shares Change (YoY) | +0.33% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.58% |
| Owned by Institutions (%) | 15.91% |
| Float | 6.06M |
Valuation Ratios
The trailing PE ratio is 13.98 and the forward PE ratio is 12.75.
| PE Ratio | 13.98 |
| Forward PE | 12.75 |
| PS Ratio | 0.37 |
| PB Ratio | 0.99 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.82 |
| P/OCF Ratio | 3.39 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.47, with an EV/FCF ratio of 13.15.
| EV / Earnings | 48.09 |
| EV / Sales | 1.27 |
| EV / EBITDA | 7.47 |
| EV / EBIT | 15.94 |
| EV / FCF | 13.15 |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 2.66.
| Current Ratio | 0.91 |
| Quick Ratio | 0.48 |
| Debt / Equity | 2.66 |
| Debt / EBITDA | 5.84 |
| Debt / FCF | 10.28 |
| Interest Coverage | 2.45 |
Financial Efficiency
Return on equity (ROE) is 7.73% and return on invested capital (ROIC) is 4.09%.
| Return on Equity (ROE) | 7.73% |
| Return on Assets (ROA) | 2.90% |
| Return on Invested Capital (ROIC) | 4.09% |
| Return on Capital Employed (ROCE) | 6.40% |
| Weighted Average Cost of Capital (WACC) | 3.40% |
| Revenue Per Employee | 101,679 |
| Profits Per Employee | 2,690 |
| Employee Count | 9,000 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 3.51 |
Taxes
In the past 12 months, LNA Santé has paid 14.06 million in taxes.
| Income Tax | 14.06M |
| Effective Tax Rate | 35.34% |
Stock Price Statistics
The stock price has increased by +37.08% in the last 52 weeks. The beta is 0.47, so LNA Santé's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | +37.08% |
| 50-Day Moving Average | 29.39 |
| 200-Day Moving Average | 26.27 |
| Relative Strength Index (RSI) | 71.49 |
| Average Volume (20 Days) | 3,826 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LNA Santé had revenue of EUR 912.67 million and earned 24.15 million in profits. Earnings per share was 2.35.
| Revenue | 912.67M |
| Gross Profit | 251.52M |
| Operating Income | 72.91M |
| Pretax Income | 39.77M |
| Net Income | 24.15M |
| EBITDA | 95.62M |
| EBIT | 72.91M |
| Earnings Per Share (EPS) | 2.35 |
Balance Sheet
The company has 94.83 million in cash and 907.25 million in debt, with a net cash position of -812.42 million or -79.21 per share.
| Cash & Cash Equivalents | 94.83M |
| Total Debt | 907.25M |
| Net Cash | -812.42M |
| Net Cash Per Share | -79.21 |
| Equity (Book Value) | 341.50M |
| Book Value Per Share | 32.20 |
| Working Capital | -39.48M |
Cash Flow
In the last 12 months, operating cash flow was 99.42 million and capital expenditures -11.13 million, giving a free cash flow of 88.29 million.
| Operating Cash Flow | 99.42M |
| Capital Expenditures | -11.13M |
| Depreciation & Amortization | 22.71M |
| Net Borrowing | -28.68M |
| Free Cash Flow | 88.29M |
| FCF Per Share | 8.61 |
Margins
Gross margin is 27.56%, with operating and profit margins of 7.99% and 2.65%.
| Gross Margin | 27.56% |
| Operating Margin | 7.99% |
| Pretax Margin | 4.36% |
| Profit Margin | 2.65% |
| EBITDA Margin | 10.48% |
| EBIT Margin | 7.99% |
| FCF Margin | 9.67% |
Dividends & Yields
This stock pays an annual dividend of 0.95, which amounts to a dividend yield of 2.91%.
| Dividend Per Share | 0.95 |
| Dividend Yield | 2.91% |
| Dividend Growth (YoY) | 46.15% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 27.63% |
| Buyback Yield | -0.33% |
| Shareholder Yield | 2.58% |
| Earnings Yield | 7.16% |
| FCF Yield | 26.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for LNA Santé is 32.50, which is -1.22% lower than the current price. The consensus rating is "Buy".
| Price Target | 32.50 |
| Price Target Difference | -1.22% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 6.52% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LNA Santé has an Altman Z-Score of 0.83 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.83 |
| Piotroski F-Score | 5 |